KMID : 1143920210250040571
|
|
Annals of Hepato-Biliary-Pancreatic Surgery 2021 Volume.25 No. 4 p.571 ~ p.574
|
|
Long-term outcomes of emergency ABO-incompatible living donor liver transplantation using a modified desensitization protocol for highly sensitized patients with acute liver failure: A case report
|
|
Lee Bo-Ram
Cho Jai-Young Han Ho-Seong Yoon Yoo-Seok Lee Hae-Won Lee Jun-Suh Kim Moon-Hwan Choi Young-Rok
|
|
Abstract
|
|
|
Although there is no established desensitization protocol for liver transplantation (LT), desensitization usually entails treatment with rituximab, plasmapheresis, splenectomy, and intravenous immunoglobulin (IVIG) infusion together with a local graft. The desensitization protocol is usually initiated 2 to 3 weeks before transplantation. Therefore, patients with acute liver failure warranting urgent LT are usually ineligible for ABO-incompatible (ABOi) LT. For these reasons, several attempts have been made to abridge the desensitization protocol and extend the indication for ABOi living donor LT (LDLT). Here we report a 40-year-old female diagnosed with chronic hepatitis B and acute-on-chronic liver failure (model for end-stage liver disease score, 31). In the absence of a suitable compatible liver donor, emergency ABOi LT was planned using a modified desensitization protocol. The preoperative isoagglutinin (IA) titer was 1 : 1,024 and the preoperative T- and B-cell cross-matches were positive. The patient received a single dose of rituximab (375 mg/m2) and IVIG (0.8 g/kg) was administered from the anhepatic phase until three days after transplantation. Although the patient developed acute cellular rejection in the early stages after LT, she has maintained a stable graft function, even after 5 years. In summary, a modified desensitization protocol consisting of rituximab and IVIG is a feasible strategy for highly sensitized patients with elevated IA titers indicated for urgent LDLT.
|
|
KEYWORD
|
|
Liver transplantation, Graft rejection, Immunoglobulins, intravenous, Liver failure, acute
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|